Study to Evaluate the Pharmacokinetics and Pharmacodynamics of JMI-001

Summary

This will be a double-blind, placebo-controlled study with a 4-way crossover design with subjects administered study drug (JMI-001), placebo, fexofenadine alone and naproxen alone on different study days, in conjunction with a quantity of alcohol estimated to be sufficient to produce a hangover the next day. The primary objective of the study is the evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of two different doses of JMI-001 administered in conjunction with alcohol to healthy adult subjects.

Timeline

Start

2017-08

Primary completion

2017-10

Completion

2017-12

Drugs

Indications

No indication recorded.